ANTIMICROBIAL GAS RELEASING AGENTS AND SYSTEMS AND METHODS FOR USING THE SAME
BACKGROUND OF THE INVENTION
Field of the Invention
[0001] This invention relates to systems and methods for reducing and preventing the growth of microbes, or for killing microbes, within an interior space of a container and/or on product/good that is stored in the package. More particularly, the invention relates to systems and methods for reducing and preventing growth of microbes, or for killing microbes, e.g., in food containers, using polymers entrained with antimicrobial releasing agents.
Description of Related Art
[0002] There are many items that are preferably stored, shipped and/or utilized in an environment that must be controlled and/or regulated. For example, in the moisture control field, containers and/or packages having the ability to absorb excess moisture trapped therein have been recognized as desirable. Likewise, in packaging products that carry a risk of contamination, e.g., food, it may be desirable to control the growth and proliferation of microbes.
[0003] Food products, particularly sliced or cut fresh foodstuffs such as meat, poultry, fruit, and vegetables are typically stored and sold in a supporting container, e.g., tray, that is overwrapped by a transparent plastic film, enabling visual inspection of the food products. These food products generally produce an exudate (i.e., juices), which can be a source for the growth of microbial agents. In addition, contamination of processing equipment or other surfaces with which the food products come into contact may remain with the food and proliferate while packaged. Similarly, food products may be contaminated even before the packaging process. For example, a tomato may have an opening in its skin through which unwanted microorganisms enter and replicate. Breakdown in the food handling process and/or cold chain management (e.g., refrigeration during food transport breaks for several hours) can allow microbial growth of contaminated food, potentially leading to outbreaks of food borne illness. Regardless of the source or nature of microbial contamination in food, the shelf-life and safety of the contaminated food products is affected by contamination and
proliferation of microbes.
[0004] One way that the food industry has addressed problems associated with foodstuffs is by including food grade preservatives as a component of the food, such as potassium sorbate, sodium benzoate and nitrites. However, such preservatives are regarded by some in the health field and consumers as being unnatural and presenting health risks. Moreover, it is not practical to use such preservatives with non-processed foods, for example fresh fruits or vegetables.
[0005] Another way that the food industry has addressed food safety is to utilize antimicrobial agents that directly contacts the food as a component in packaging material. However, such direct contact may be undesirable in some applications.
[0006] For certain applications, it is desirable to provide antimicrobial agents to release antimicrobial gas into a headspace of the food product package or container to control the growth of microbes, as compared to a solid or liquid component that requires direct contact with the stored food in order to be effective. However, there are challenges with providing the antimicrobial gas in the headspace. One such challenge is attaining a desired release profile of antimicrobial gas within the headspace during a designated time period. Failure to attain the appropriate release profile for a given product may result in a failure to achieve the desired shelf life for that product. Thus, there exists a need for improved delivery of antimicrobial agents to control, reduce and substantially destroy microbial contamination in food packaging as well as other applications, such as but not limited to, packaging of sterilized disposable medical devices. A challenge in meeting this need is maintaining a balance between providing sufficient antimicrobial gas in the package headspace to effectively control and/or kill pathogens while not“overdosing” the package headspace, which could adversely affect the quality of the product, e.g., by organoleptic degradation.
SUMMARY OF THE INVENTION
[0007] Accordingly, in one aspect, the invention provides an entrained polymer comprising a base polymer, a chlorine dioxide gas releasing agent, and a channeling agent. The chlorine dioxide gas releasing agent includes an active component, a catalyst, and a trigger. Optionally, the entrained polymer on a per gram basis releases the chlorine dioxide gas in a
concentration of 3 ppm to 1000 ppm, optionally 10 ppm to 1000 ppm, optionally 30 ppm to 1000 ppm, optionally 60 ppm to 1000 ppm, optionally 100 ppm to 1000 ppm, optionally 150 ppm to 1000 ppm, optionally 200 ppm to 1000 ppm, optionally 50 ppm to 800 ppm, optionally 100 ppm to 800 ppm, wherein the concentration is measured using the entrained polymer in a quantity of 2 grams placed in a 1 L chamber at 25 °C in the presence of 1 g of water, wherein the 1 g of water is sequestered to a piece of filter paper having no direct contact with the entrained polymer.
[0008] Optionally, under the aforementioned conditions, the entrained polymer releases the chlorine dioxide gas in a concentration of at least 3 ppm, optionally at least 10 ppm, optionally at least 50 ppm, optionally at least 100 ppm, optionally at least 150 ppm, or optionally at least 300 ppm 1 hour post-initiation.
[0009] Optionally, in any embodiment, the chlorine dioxide gas releasing agent is provided in at least one entrained polymer article located within the interior space. The entrained polymer article is a monolithic material that includes a base polymer, the chlorine dioxide gas releasing agent and a channeling agent. Preferably, such entrained polymer is provided as a film having a thickness of from 0.1 mm to 1.0 mm, preferably from 0.2 mm to 0.6 mm, optionally about 0.2 or 0.3 mm. Alternatively, such entrained polymer may be produced in a hot melt application in which the entrained polymer composition has a melt flow index in a range from 200 g/10 min to 5000 g/10 min under the ASTM D1238 / ISO 1133 conditions. Optionally, such entrained polymer composition has a viscosity in a range from 1,000 cp to 50,000 cp, when viscosity is measured with a rheometer at 190° C after shearing at 5 Hz for two minutes. Hot melt dispensing apparatus and methods, which may optionally be used to dispense an entrained polymer comprising chlorine dioxide releasing agents, are described in PCT/US2018/049578, which is incorporated by reference herein in its entirety.
[0010] Accordingly, in one aspect, the invention provides a system to inhibit or prevent growth of microbes and/or to kill microbes in a closed container having a good that is located therein. The system optionally includes a container including a bottom surface, a top opening, one or more sidewalls extending in a vertical direction from the bottom surface to the top opening, an interior space formed by the one or more sidewalls, a headspace formed
by the interior space that is not occupied by the good, and a cover to close and/or seal the container. The system also includes at least one entrained polymer article located within the interior space that includes a monolithic material, which includes a base polymer, and an antimicrobial releasing agent configured to release a released antimicrobial gas. The system further includes a selected material present in the interior space to activate the release of the released antimicrobial gas.
[0011] In another aspect, the invention provides a method for inhibiting or preventing the growth of microbes and/or for killing microbes in a closed container having a good located therein. The method includes forming at least one entrained polymer article, which includes obtaining a base polymer, and combining an antimicrobial releasing agent with the base polymer to form a monolithic material, wherein the antimicrobial releasing agent is configured to release a released antimicrobial material in gas form upon being activated by a selected material, e.g., moisture. The method also includes obtaining a container that includes a bottom surface, a top opening, one or more sidewalls extending in a vertical direction from the bottom surface to the top opening, an interior space formed by the one or more sidewalls, a headspace formed by the interior space that is not occupied by the good, and a cover to close and/or seal the container. The method further includes positioning the at least one entrained polymer article within the interior space of the container; placing the good in the container; covering the container; presenting the selected material in the interior space of the container; and releasing the released antimicrobial material within the interior space in a concentration effective for reducing or preventing the growth of microbes and/or for killing microbes present in and/or on the good.
[0012] In another aspect, a package is provided for inhibiting or preventing growth of microbes and/or for killing microbes in a closed container having a product located therein. The package includes a closed container defining an interior space therein. A product (optionally a food product) is provided within the interior space. A headspace is formed within a volume of the interior space that is not occupied by the product. An antimicrobial releasing agent is disposed within the interior space, the antimicrobial releasing agent releasing chlorine dioxide gas into the headspace by reaction of moisture with the antimicrobial releasing agent. The antimicrobial releasing agent is provided in an amount
that releases the chlorine dioxide gas to provide a headspace concentration of from 6 parts per million (PPM) to 35 PPM for a period of 10 hours to 36 hours, optionally from 15 PPM to 30 PPM for a period of 16 hours to 36 hours, optionally from 15 PPM to 30 PPM for a period of about 24 hours.
[0013] Optionally, in any embodiment, when the product is provided within the interior space, the product is contaminated by at least one type of pathogen. The antimicrobial releasing agent provides a controlled release of chlorine dioxide gas to effectuate, after a span of 2 days, optionally 3 days, optionally 4 days, optionally 5 days, optionally 6 days, optionally 7 days, optionally 8 days, optionally 9 days, optionally 10 days, optionally 11 days, optionally 12 days, optionally 13 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 2 log base 10 reduction in CFU/g, optionally at least a 3 log base 10 reduction in CFU/g, of the at least one type of pathogen, optionally at least a 4 log base 10 reduction in CFU/g, of the at least one type of pathogen. Optionally, the at least one pathogen is Salmonella, E. Coli, Listeria and/or Geotrichum.
[0014] Optionally, if the product is a food product and the amount of antimicrobial releasing agent and/or chlorine dioxide gas is present in an amount sufficient to effectuate the at least 1 log base 10 reduction in CFU/g (or at least 2 log base 10 reduction or at least 3 log base 10 reduction or at least 4 log base 10 reduction in CFU/g), of the at least one type of pathogen, such efficacy does not come at the expense of organoleptic degradation of the food product. For example the food product is not bleached or otherwise discolored, as perceived by an ordinary consumer without special detection equipment (i.e., no substantial organoleptic degradation).
[0015] Optionally, in any embodiment, the antimicrobial releasing agent is provided in at least one entrained polymer article located within the interior space. The entrained polymer article is a monolithic material that includes a base polymer, the antimicrobial releasing agent and optionally a channeling agent. Preferably, such entrained polymer is provided as a film having a thickness of from 0.1 mm to 1.0 mm, preferably from 0.2 mm to 0.6mm, optionally about 0.3 mm. Preferably, such film is provided above the midline (preferably at least 2/3 or
3/4) of the container sidewalls, which inventors have found helps to attain a desired antimicrobial gas release profile.
[0016] Optionally, in any embodiment, the antimicrobial releasing agent is a powdered mixture comprising an alkaline metal chlorite, preferably sodium chlorite. The powdered mixture further comprises at least one catalyst, optionally sulfuric acid clay, and at least one humidity trigger, optionally calcium chloride.
[0017] Optionally, in any embodiment, a method is provided for inhibiting or preventing the growth of microbes and/or for killing microbes in a closed container having a food product located therein. The method includes providing a closed container defining an interior space therein and a food product within the interior space. A headspace is formed within a volume of the interior space that is not occupied by the product. An antimicrobial releasing agent (such as that disclosed in this Summary section and elsewhere in this specification) is provided in the interior space. The agent releases an antimicrobial gas into the headspace by reaction of moisture with the antimicrobial releasing agent. The antimicrobial releasing agent is provided in an amount sufficient to release the antimicrobial gas to provide a desired headspace concentration of the antimicrobial gas over a predetermined amount of time. According to the method, if the product is contaminated by at least one type of pathogen at the time the product is provided within the interior space, the antimicrobial releasing agent optionally provides a controlled release of antimicrobial gas to effectuate, after a span of 2 days, optionally 3 days, optionally 4 days, optionally 5 days, optionally 6 days, optionally 7 days, optionally 8 days, optionally 9 days, optionally 10 days, optionally 11 days, optionally 12 days, optionally 13 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 2 log base 10 reduction in CFU/g, optionally at least a 3 log base 10 reduction in CFU/g, of the at least one type of pathogen, optionally at least a 4 log base 10 reduction in CFU/g, of the at least one type of pathogen. Preferably, this method effectuates the reduction without causing substantial or reasonably perceptible (to the consumer) organoleptic degradation of the food product, for example without bleaching or otherwise causing noticeable discoloration of the food product. Preferably, the antimicrobial releasing agent is provided in an entrained polymer more preferably in an entrained polymer
film, for example as described herein.
[0018] Optionally, in any embodiment of a package described herein, an aspect of the invention may include use of the package for storing a food product, wherein the food product exudes moisture that activates the antimicrobial releasing agent to release chlorine dioxide gas in the headspace. This use may attain desired headspace antimicrobial gas concentrations as described herein. This use may effectuate, after a span of 2 days, optionally 3 days, optionally 4 days, optionally 5 days, optionally 6 days, optionally 7 days, optionally 8 days, optionally 9 days, optionally 10 days, optionally 11 days, optionally 12 days, optionally 13 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 2 log base 10 reduction in CFU/g, optionally at least a 3 log base 10 reduction in CFU/g, of the at least one type of pathogen, optionally at least a 4 log base 10 reduction in CFU/g, of the at least one type of pathogen. This is preferably done without causing substantial organoleptic degradation of the food product, for example without noticeably bleaching or otherwise discoloring the food product.
BRIEF DESCRIPTION OF THE DRAWINGS
[0019] The invention will be described in conjunction with the following drawings in which like reference numerals designate like elements and wherein:
[0020] FIG. 1 is a perspective view of a plug formed of an entrained polymer according to an optional embodiment of the present invention.
[0021] FIG. 2 is a cross section taken along line 2-2 of FIG. 1;
[0022] FIG. 3 is a cross section similar to that of FIG. 2, showing a plug formed of another embodiment of an entrained polymer according to an optional embodiment of the present invention;
[0023] FIG. 4 is a schematic illustration of an entrained polymer according to an optional embodiment of the present invention, in which the active agent is an antimicrobial gas releasing material that is activated by contact with a selected material (e.g., moisture).
[0024] FIG. 5 is a cross sectional view of a sheet or film formed of an entrained polymer according to an optional embodiment of the present invention, adhered to a barrier sheet substrate.
[0025] FIG. 6 is a cross section of a package that may be formed using an entrained polymer according to an optional embodiment of the present invention.
[0026] FIG. 7 is a perspective view of an exemplary package incorporating entrained polymer films according to an optional aspect of the present invention.
[0027] FIGS. 8 A and 8B are plots comparing Geotrichum Growth on contaminated tomatoes stored in packages respectively with and without use of antimicrobial entrained polymer film.
[0028] FIG. 9 is a plot showing the measured amount of C102 (chlorine dioxide) provided within a headspace of a container including entrained polymer film, in accordance with certain embodiments of the invention.
[0029] FIG. 10 is a plot showing the measured amount of C102 provided within a headspace of a container including an entrained polymer film positioned at varying heights on the sidewall, in accordance with certain embodiments of the invention.
[0030] FIG. 11 is a plot showing the log CFU/gram reduction in Salmonella for foodstuff
stored in containers with an entrained polymer film being positioned therein, in accordance with certain embodiments, as compared to containers absent of the entrained polymer film.
[0031] FIG. 12 is a plot showing the log CFU/gram reduction in E. Coli for foodstuff stored in containers with an entrained polymer film being positioned therein, in accordance with certain embodiments, as compared to containers without the entrained polymer film.
[0032] FIG. 13 is a plot showing the log CFU/gram reduction in Listeria for foodstuff stored in containers with an entrained polymer film being positioned therein, in accordance with certain embodiments, as compared to containers without the entrained polymer film.
[0033] FIG. 14 is a plot showing the measured amounts of CIO2 provided within a headspace of a container depending on the amount of entrained antimicrobial polymer film provided in the container.
[0034] FIG. 15 is a first plot showing the measured amounts of CIO2 provided within a headspace under Method Two conditions described in the Detailed Description.
[0035] FIG. 16 is a second plot showing the measured amounts of CIO2 provided within a headspace under Method Two conditions described in the Detailed Description.
[0036] FIG. 17 is a third plot showing the measured amounts of CIO2 provided within a headspace under Method Two conditions described in the Detailed Description.
[0037] FIG. 18 is a fourth plot showing the measured amounts of CIO2 provided within a headspace under Method Two conditions described in the Detailed Description.
[0038] FIG. 19 is a fifth plot showing the measured amounts of CIO2 provided within a headspace under Method Two conditions described in the Detailed Description.
[0039] FIG. 20 is a first plot showing the measured amounts of CIO2 provided within a headspace under Method One conditions described in the Detailed Description.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
Definitions
[0040] As used herein, the term“active” is defined as capable of acting on, interacting with or reacting with a selected material (e.g., moisture or oxygen) according to the invention. Examples of such actions or interactions may include absorption, adsorption or release (for
example, as a result of a chemical reaction) of the selected material. Another example of “active”, which is pertinent to a primary focus of the present invention is an agent capable of acting on, interacting with or reacting with a selected material in order to cause release of a released material.
[0041] As used herein, the term“active agent” is defined as a material that (1) is preferably immiscible with the base polymer and when mixed and heated with the base polymer and the channeling agent, will not melt, i.e., has a melting point that is higher than the melting point for either the base polymer or the channeling agent, and (2) acts on, interacts or reacts with a selected material. The term“active agent” may include but is not limited to materials that absorb, adsorb or release (for example, as a result of a chemical reaction) of the selected material(s). The active agents of primary focus in this specification are those that release antimicrobial gas(es), preferably chlorine dioxide gas, upon contact with the selected material(s).
[0042] The term“antimicrobial releasing agent” refers to an active agent that is capable of releasing a released antimicrobial material, e.g. in gas form. This active agent includes an active component and other components (such as a catalyst and trigger) in a formulation (e.g., powdered mixture) configured to release the antimicrobial material, e.g. antimicrobial gas. A“released antimicrobial material” is a compound that inhibits or prevents the growth and proliferation of microbes and/or kills microbes, e.g., chlorine dioxide gas. The released antimicrobial material is released by the antimicrobial releasing agent. By way of example only, an antimicrobial releasing agent may be activated (e.g., by chemical reaction or physical change) by contact with a selected material (such as moisture). For example, moisture may react with an antimicrobial releasing agent to cause the agent to release a released antimicrobial material.
[0043] As used herein, the term“base polymer” is defined as a polymer optionally having a gas transmission rate of a selected material that is substantially lower than, lower than or substantially equivalent to, that of the channeling agent. By way of example, such a transmission rate is a water vapor transmission rate in embodiments where the selected material is moisture and the active agent is an antimicrobial gas releasing agent that is activated by moisture. This active agent includes an active component and other components
in a formulation configured to release the antimicrobial gas. The primary function of the base polymer is to provide structure for the entrained polymer. The base polymer also enables molding or extruding an article having a monolithic composition.
[0044] Suitable base polymers for use in the invention include thermoplastic polymers, e.g., polyolefins such as polypropylene and polyethylene, polyisoprene, polybutadiene, polybutene, polysiloxane, polycarbonates, polyamides, ethylene-vinyl acetate copolymers, ethylene-methacrylate copolymer, poly(vinyl chloride), polystyrene, polyesters, polyanhydrides, polyacrylonitrile, polysulfones, polyacrylic ester, acrylic, polyurethane and polyacetal, or copolymers or mixtures thereof.
[0045] In certain embodiments, the channeling agent has a water vapor transmission rate of at least two times that of the base polymer. In other embodiments, the channeling agent has a water vapor transmission rate of at least five times that of the base polymer. In other embodiments, the channeling agent has a water vapor transmission rate of at least ten times that of the base polymer. In still other embodiments, the channeling agent has a water vapor transmission rate of at least twenty times that of the base polymer. In still another embodiment, the channeling agent has a water vapor transmission rate of at least fifty times that of the base polymer. In still other embodiments, the channeling agent has a water vapor transmission rate of at least one hundred times that of the base polymer.
[0046] As used herein, the term“channeling agent” or“channeling agents” is defined as a material that is immiscible with the base polymer and has an ability to transport a gas phase substance at a faster rate than the base polymer. Optionally, a channeling agent is capable of forming channels through the entrained polymer when formed by mixing the channeling agent with the base polymer. Optionally, such channels are capable of transmitting a selected material through the entrained polymer at a faster rate than in solely the base polymer.
[0047] As used herein, the term“channels” or“interconnecting channels” is defined as passages formed of the channeling agent that penetrate through the base polymer and may be interconnected with each other.
[0048] As used herein, the term“entrained polymer” is defined as a monolithic material formed of at least a base polymer with an active agent and optionally also a channeling agent entrained or distributed throughout. An entrained polymer thus includes two-phase polymers
(without a channeling agent) and three-phase polymers (with a channeling agent).
[0049] As used herein, the term “monolithic,” “monolithic structure” or “monolithic composition” is defined as a composition or material that does not consist of two or more discrete macroscopic layers or portions. Accordingly, a“monolithic composition” does not include a multi-layer composite (although could be used as a component of such a composite).
[0050] As used herein, the term“phase” is defined as a portion or component of a monolithic structure or composition that is uniformly distributed throughout, to give the structure or composition its monolithic characteristics.
[0051] As used herein, the term“selected material” is defined as a material that is acted upon, by, or interacts or reacts with an active agent and is capable of being transmitted through the channels of an entrained polymer. For example, in embodiments in which a releasing material is the active agent, the selected material may be moisture that reacts with or otherwise causes the active agent to release a releasing material, such as an antimicrobial gas.
[0052] As used herein, the term“three phase” is defined as a monolithic composition or structure comprising three or more phases. An example of a three phase composition according to the invention is an entrained polymer formed of a base polymer, active agent, and channeling agent. Optionally, a three phase composition or structure may include an additional phase, e.g., a colorant, but is nonetheless still considered“three phase” on account of the presence of the three primary functional components.
[0053] Furthermore, the terms “package,” “packaging” and “container” may be used interchangeably herein to indicate an object that holds or contains a good, e.g., food product and foodstuffs. Optionally, a package may include a container with a product stored therein. Non- limiting examples of a package, packaging and container include a tray, box, carton, bottle receptacle, vessel, pouch and flexible bag. A pouch or flexible bag may be made from, e.g., polypropylene or polyethylene. The package or container may be closed, covered and/or sealed using a variety of mechanisms including a cover, a lid, lidding sealant, an adhesive and a heat seal, for example. The package or container is composed or constructed of various materials, such as plastic (e.g., polypropylene or polyethylene), paper, Styrofoam, glass,
metal and combinations thereof. In one optional embodiment, the package or container is composed of a rigid or semi-rigid polymer, optionally polypropylene or polyethylene, and preferably has sufficient rigidity to retain its shape under gravity.
Exemplary Entrained Polymers
[0054] Conventionally, desiccants, oxygen absorbers and other active agents, for example the antimicrobial releasing agent of the present invention, have been used in raw form, e.g., as loose particulates housed in sachets or canisters within packaging, to control the internal environment of the package. For many applications, it is not desired to have such loosely stored active substances. Thus, the present application provides active entrained polymers comprising active agents, wherein such polymers can be extruded and/or molded into a variety of desired forms, e.g., container liners, plugs, film sheets, pellets and other such structures. Optionally, such active entrained polymers may include channeling agents, such as polyethylene glycol (PEG), and vinylpyrrolidone-vinyl acetate copolymer (PVPVA), which form channels between the surface of the entrained polymer and its interior to transmit a selected material (e.g., moisture) to the entrained active agent (e.g., desiccant to absorb the moisture). As explained above, entrained polymers may be two phase formulations (i.e., comprising a base polymer and active agent, without a channeling agent) or three phase formulations (i.e., comprising a base polymer, active agent and channeling agent). Entrained polymers comprising channeling agents are described, for example, in U.S. Pat. Nos.
5,911,937, 6,080,350, 6,124,006, 6,130,263, 6,194,079, 6,214,255, 6,486,231, 7,005,459, and U.S. Pat. Pub. No. 2016/0039955, each of which is incorporated herein by reference as if fully set forth.
[0055] Figs. 1-6 illustrate exemplary entrained polymers 20 and various packaging assemblies formed of entrained polymers according to certain embodiments of the invention. The entrained polymers 20 each include a base polymer 25, optionally a channeling agent 35 and an active agent 30. As shown, the channeling agent 35 forms interconnecting channels 45 through the entrained polymer 20. At least some of the active agent 30 is contained within these channels 45, such that the channels 45 communicate between the active agent 30 and the exterior of the entrained polymer 20 via channel openings 48 formed at outer surfaces of
the entrained polymer 25. The active agent 30 can be, for example, any one of a variety of antimicrobial releasing materials, as described in further detail below. While a channeling agent, e.g., 35, is preferred, the invention broadly includes entrained polymers that optionally do not include a channeling agent.
[0056] Suitable channeling agents include polyglycol such as polyethylene glycol (PEG), ethylene-vinyl alcohol (EVOH), polyvinyl alcohol (PVOH), glycerin polyamine, polyurethane and polycarboxylic acid including polyacrylic acid or polymethacrylic acid. Alternatively, the channeling agent 35 can be, for example, a water insoluble polymer, such as a propylene oxide polymerisate-monobutyl ether, which is commercially available under the trade name Polyglykol B01/240, produced by CLARIANT. In other embodiments, the channeling agent could be a propylene oxide polymerisate monobutyl ether, which is commercially available under the trade name Polyglykol B01/20, produced by CLARIANT, propylene oxide polymerisate, which is commercially available under the trade name Polyglykol DO 1/240, produced by CLARIANT, ethylene vinyl acetate, nylon 6, nylon 66, or any combination of the foregoing. Alternatively, the channeling agent 35 can also be a water soluble agent, such as vinylpyrrolidone- vinyl acetate copolymer 60/40 (PVPVA 64). Certain propylene oxide polymerisate-monobutyl ethers are also water soluble.
[0057] Entrained polymers with antimicrobial releasing agents are further described below.
Antimicrobial Releasing Agents and Optional
Entrained Polymer Formulations Incorporating the Same
[0058] Suitable active agents according to the invention include antimicrobial releasing agents. FIG. 4 illustrates an embodiment of an entrained polymer 10 according to the invention, in which the active agent 30 is an antimicrobial releasing agent. The arrows indicate the path of a selected material, for example moisture or another gas, from an exterior of the entrained polymer 10, through the channels 45, to the particles of active agent 30 (in this case, an antimicrobial releasing agent). Optionally, the antimicrobial releasing agent reacts with or is otherwise triggered or activated by the selected material (e.g., by moisture) and in response releases a released antimicrobial material, preferably in gas form.
[0059] The antimicrobial agents useful herein include volatile antimicrobial releasing agents, non-volatile antimicrobial releasing agents and combinations thereof.
[0060] The term“volatile antimicrobial releasing agent” includes any compound that when it comes into contact with a fluid (e.g., water or the juice from a food product), produces a gas and/or gas phase such as vapor of released antimicrobial agent. As will be discussed in greater detail below, the volatile antimicrobial releasing agent is generally used in a closed system so that the released antimicrobial material (gas and/or vapor) does not escape.
[0061] The term“non-volatile antimicrobial agent” includes any compound that when it comes into contact with a fluid (e.g., water or the juice from a food product), produces minimal to no vapor of antimicrobial agent. Examples of non-volatile antimicrobial agents include, but are not limited to, ascorbic acid, a sorbate salt, sorbic acid, citric acid, a citrate salt, lactic acid, a lactate salt, benzoic acid, a benzoate salt, a bicarbonate salt, a chelating compound, an alum salt, nisin, e-polylysine 10%, methyl and/or propyl parabens, or any combination of the foregoing compounds. The salts include the sodium, potassium, calcium, or magnesium salts of any of the compounds listed above. Specific examples include calcium sorbate, calcium ascorbate, potassium bisulfite, potassium metabisulfite, potassium sorbate, or sodium sorbate.
[0062] Preferred features of antimicrobial releasing agents used according to an aspect of the present invention include any one or more of the following characteristics: (1) they volatize at refrigerated temperatures; (2) they are food safe and edible in finished form; (3) they may be incorporated safely into an entrained polymer formulation or other mechanism for release; (4) they are shelf stable in long term storage conditions; (5) they release the released antimicrobial material only once a package in which the agent is disposed, is sealed with product disposed in the package; (6) they do not substantially affect a stored food product organoleptically when they are formulated and configured to achieve a desired release profile within the package; and (7) they are preferably acceptable under applicable governmental regulations and/or guidelines pertaining to food packaging and finished food labeling.
Chlorine Dioxide Releasing Antimicrobial Releasing Agents
[0063] In one aspect of the invention, preferred antimicrobial releasing agents are volatile antimicrobial agents that release chlorine dioxide (CIO2) in gas form as the released
antimicrobial material. For example, the antimicrobial releasing agent may be a compound or formulation comprising an alkaline chlorite, such as, e.g. sodium chlorite or potassium chlorite, a catalyst and a trigger (e.g., in the form of a powder) which in combination are triggered or activated by moisture to cause the agent to release chlorine dioxide. One exemplary antimicrobial releasing agent is provided under the brand ASEPTROL 7.05 by BASF Catalysts LLC. This material and preparation of the same is described in U.S. Pat. No. 6,676,850, which is incorporated by reference in its entirety. Example 6 of the aforementioned patent describes a formulation that is particularly suitable as an antimicrobial releasing agent, according to an optional aspect of the invention.
[0064] Optionally, a suitable antimicrobial releasing agent, which is based on Example 6 of U.S. Pat. No. 6,676,850 and is configured to release chlorine dioxide gas upon activation by moisture, may be prepared as follows.
[0065] The antimicrobial releasing agent includes a formulation comprising sodium chlorite (as the active component), a base catalyst and a trigger. The catalyst and trigger preparations are made separately, then combined together and ultimately combined with the sodium chlorite.
[0066] The base catalyst is optionally made by first preparing a 25-30 wt. % sodium silicate solution (Si02:Na20 proportion of 2.0 to 3.3 by weight). That solution is mixed into an aqueous slurry of 28-44 wt. % Georgia Kaolin Clay (particle size diameter of about 80% less than one micrometer), wherein the sodium silicate solution is 2 wt. % of the slurry. The slurry is oven dried at 100° C to generate agglomerates or microspheres of about 70pm in size. 300g of these microspheres are impregnated with 280g of 2.16N sulfuric acid solution. That mixture is then dried at 100° C. Next, the dried mixture undergoes a calcine process at 350° C for 3 hours, followed by an additional calcine process at 300° C in a sealed glass jar with the seal wrapped with tape. This mixture forms the base catalyst.
[0067] Next, 84.6 g of the base catalyst are mixed with 10.1 g of the trigger, dry calcium chloride. This base catalyst and trigger mixture is ground with mortar and pestle at ambient room temperature. This mixture is dried for 2 hours at 200° C. The base catalyst and trigger mixture is then cooled to room temperature in a sealed glass jar with tape wrapped around the seal.
[0068] Finally, the base catalyst and trigger mixture is combined with 5.3g of sodium chlorite (which is the active component of the active agent). The full mixture is then ground with mortar and pestle at ambient room temperature, thus forming an optional embodiment of an antimicrobial releasing agent. The antimicrobial releasing agent is then deposited in a sealed glass jar with tape wrapped around the seal to preserve it and keep it essentially free of moisture, which would prematurely activate it (to release chlorine dioxide gas).
[0069] Optionally, the antimicrobial releasing agent is a component of an entrained polymer, preferably a three phase polymer comprising the active agent (e.g., 30%-70% by weight), a base polymer and a channeling agent (e.g., 1%-16% by weight). Optionally, such entrained polymer is in the form of a film disposed within sealed packaging containing fresh foodstuffs, e.g., meat or produce.
[0070] It is generally believed that the higher the antimicrobial releasing agent concentration in an entrained polymer mixture, the greater the absorption, adsorption or releasing capacity of the final composition. However, too high an active agent concentration may cause the entrained polymer to be too brittle. This may also cause the molten mixture of active agent, base polymer and (if used) channeling agent to be more difficult to either thermally form, extrude or injection mold. Furthermore, excessive loadings of the antimicrobial releasing agent may cause discoloration or otherwise undesirable organoleptic changes to the foodstuffs stored with and exposed to the released antimicrobial gas (depending on various factors).
[0071] In any embodiment, the antimicrobial releasing agent loading level or concentration can range from 20% to 80%, optionally 30% to 70%, optionally 30% to 60%, optionally 30% to 50%, optionally from 35% to 70%, optionally from 35% to 60%, optionally from 35% to 55%, optionally from 35% to 50%, optionally 40% to 70%, optionally from 40% to 60%, optionally from 40% to 50%, optionally from 45% to 60%, optionally from 50% to 60% by weight with respect to the total weight of the entrained polymer.
[0072] In any embodiment, , the channeling agent may be provided in a range of 1% to 16%, optionally 1% to 14%, optionally from 1% to 12%, optionally from 1% to 10%, optionally from 1% to 8%, optionally from 1% to 6%, optionally from 1% to 5%, optionally from 1%
to 4%, optionally from 2% to 16%, optionally from 2% to 14%, optionally from 2% to 12%, optionally from 2% to 10%, optionally from 2% to 8%, optionally from 2% to 6%, optionally from 2% to 5%, optionally from 2% to 4%, optionally from 4% to 12%, optionally from 4% to 10%, optionally from 4% to 8%, optionally from 4% to 6%, optionally from 4% to 5%, optionally from 6% to 12%, optionally from 6% to 10%, optionally from 6% to 8%, optionally from 8% to 12%, optionally from 8% to 10% by weight of the entrained polymer.
[0073] In any embodiment,, the base polymer may range from 10% to 70%, optionally from 20% to 60%, optionally from 20% to 50%, optionally from 20% to 40%, optionally from 30% to 70%, optionally from 30% to 60%, from 30% to 50%, optionally from 40% to 70%, optionally from 40% to 60%, optionally from 40% to 50% by weight of the total composition.
[0074] Optionally, a colorant is added, e.g., at about 1% to 2% by weight of the entrained polymer.
[0075] The invention provides an entrained polymer according to the composition described above to provide a wide range of the desired properties characterizing the released gas. Such properties include but are not limited to rapidity of or delayed release, rate of release, duration of release, peak concentration, and hold pattern. The desired properties may be dictated by the foodstuffs or the product to be protected, in combination with the ambient humidity level.
[0076] As an example, sliced tomatoes are a high moisture exuding food. The typical time between farm processing and retail points is about 36-96 hours. To effectively protect against food borne pathogens, an entrained polymer with a quick release, a high released chlorine dioxide concentration and a sustained released chlorine dioxide concentration is necessary. Yet, for commercial acceptance, the released chlorine dioxide may not bleach the sliced tomatoes or otherwise noticeably compromise the appearance of the sliced tomatoes. In contrast, cut cantaloupe is a low moisture exuding food. A longer acting entrained polymer to give a lower but sustained released chlorine dioxide concentration may be appropriate. The desired release profile is also dictated by the nature of the native or environmental microbes. The entrained polymer of the current invention provides a wide
range of release profile and serves a broad range of needs that may be specific to the products protected.
[0077] In one embodiment, an entrained polymer may be a three phase formulation including 50% by weight of ASEPTROL 7.05 antimicrobial releasing agent in the form of the powdered mixture, 38% by weight ethyl vinyl acetate (EVA) as a base polymer and 12% by weight polyethylene glycol (PEG) as a channeling agent.
[0078] FIG. 1 shows a plug 55 constructed of an entrained polymer 20, in accordance with certain embodiments of the invention. The plug 55 may be placed inside of a container. As aforementioned, the entrained polymer 20 includes a base polymer 25, a channeling agent 35 and an active agent 30.
[0079] FIG. 2 shows a cross-sectional view of the plug 55 shown in FIG. 1. In addition, FIG. 2 shows that the entrained polymer 20 has been solidified such that the channeling agent 35 forms interconnecting channels 45 to establish passages throughout the solidified plug 55. At least some of the active agent 30 is contained within the channels 45, such that the channels 45 communicate between the active agent 30 and the exterior of the entrained polymer 20 via channel openings 48 formed at outer surfaces of the entrained polymer 25. In reality, these channels would be much smaller but are shown here schematically to assist in understanding the invention.
[0080] FIG. 3 illustrates an embodiment of a plug 55 having similar construction and makeup to the plug 55 of FIG. 2, where interconnecting channels 45 are finer as compared to those shown in FIG. 2. This can result from the use of a dimer agent (i.e., a plasticizer) together with a channeling agent 35. The dimer agent may enhance the compatibility between the base polymer 25 and the channeling agent 35. This enhanced compatibility is facilitated by a lower viscosity of the blend, which may promote a more thorough blending of the base polymer 25 and channeling agent 35, which under normal conditions can resist combination into a uniform solution. Upon solidification of the entrained polymer 20 having a dimer agent added thereto, the interconnecting channels 45 which are formed there through have a greater dispersion and a smaller porosity, thereby establishing a greater density of interconnecting channels throughout the plug 55.
[0081] Interconnecting channels 45, such as those disclosed herein, facilitate transmission of a desired material, such as moisture, gas or odor, through the base polymer 25, which generally acts as a barrier to resist permeation of these materials. For this reason, the base polymer 25 itself acts as a barrier substance within which an active agent 30 may be entrained. The interconnecting channels 45 formed of the channeling agent 35 provide pathways for the desired material to move through the entrained polymer 10. Without these interconnecting channels 45, it is believed that relatively small quantities of the desired material would be transmitted through the base polymer 25 to or from the active agent 30. Additionally, wherein the desired material is transmitted from the active agent 30, it may be released from the active agent 30, because the active agent 30 is an antimicrobial gas releasing material in the present invention.
[0082] FIG. 5 illustrates an active sheet or film 75 formed of the entrained polymer 20 used in combination with a barrier sheet 80 to form a composite, according to an aspect of the invention. The characteristics of the active sheet 75 are similar to those described with respect to the plug 55 shown in FIGs. 1 and 2. The barrier sheet 80 may be a substrate such as foil and/or a polymer (such as a container wall) with low moisture or oxygen permeability. The barrier sheet 80 is compatible with the active sheet 75 and thus, is configured to thermally bond to the active sheet 75, when the active sheet 75 solidifies after dispensing. FIG. 6 illustrates an embodiment in which the two sheets 75, 80 are combined to form a packaging wrap having active characteristics at an interior surface formed by the entrained polymer 20/active sheet 75, and vapor resistant characteristics at an exterior surface formed by the barrier sheet 80.
[0083] In one embodiment, the sheets 75, 80 of FIG. 5 are joined together to form an active package 85, as shown in FIG. 6. As shown, two laminates or composites are provided, each formed of an active sheet 75 joined with a barrier sheet 80. The sheet laminates are stacked, with each active sheet 75 facing the other, so as to be disposed on an interior of the package, and are joined at a sealing region 90, formed about a perimeter of the sealed region of the package interior.
[0084] Optionally, in any of the foregoing embodiments, the antimicrobial entrained
polymer is in the form of a film that is disposed within a sealed food package. Optionally, the film may be adhered, e.g., using an adhesive, to an inner surface of the package. Alternatively, the film may be heat staked (without an adhesive) to the inner surface of the package. The process of heat staking film onto a substrate is known in the art and described in detail in U.S. Pat. No. 8,142,603, which is incorporated by reference herein in its entirety. The size and thickness of the film can vary. In certain embodiments, the film has a thickness of approximately 0.3 mm. Optionally, the film may range from 0.1 mm to 1.0 mm, more preferably from 0.3 mm to 0.6 mm.
[0085] FIG. 7 shows a package 100 for storing fresh foodstuffs, e.g., produce or meat, in accordance with certain embodiments of the invention. The package 100 is shown in the form of a plastic tray 102. Although, other forms and materials are also contemplated as being within the scope of the invention. The tray 102 comprises a base 104, and sidewalls 106 extending vertically from the base 104 leading to a tray opening 108. The base 104 and sidewalls 106 together define an interior 110, e.g. for holding and storing fresh produce. The package 100 also includes a flexible plastic lidding film 112, which is disposed over and seals the opening 108. It is contemplated and understood that a wide variety of covers or lids may be used to close and seal the opening 108. Optionally, the cover or lid is transparent, such that the interior can be viewed. When a product (e.g., sliced tomatoes) is stored within the interior 110, empty space surrounding and above the product is herein referred to as “headspace” (not shown).
[0086] The package 100 further includes sections of antimicrobial entrained polymer film 114 disposed on the sidewalls 106. In the embodiment shown, there are four sections of such film 114, one section of film 114 per sidewall 106. The film 114 is preferably disposed at or near the top of the sidewall 106, proximal to the opening 108. At least a portion, although preferably most or all of each of the film sections 114 protrude above the midline 116 of the sidewall 106, the midline 116 being centrally located between the base 104 and the opening 108. It has been found that film placement at or towards the top of the package 100 has an effect on efficacy of the film sections 114, as such placement facilitates desirable distribution of released antimicrobial material into the headspace of the package 100. Placing the entrained polymer at too low of a height above the base 104, or beneath the food in the
package, has been found not to provide desirable distribution of the released antimicrobial material in the headspace. If placement mass transfer of the antimicrobial is not optimal, some of the food product/good will not be adequately protected against the growth of microbes. Additionally, the food may undesirably react with and/or absorb the released antimicrobial material. As explained further below, it has been found that placing the film above the midline of the sidewall, preferably at a height of at least 67% or 75% or about 80% of the sidewall, facilitates achieving a desired antimicrobial gas release profile and headspace concentration.
[0087] Optionally, the entrained polymer film 114 is heat staked to the package (e.g., on the sidewall as described and shown vis-a-vis Fig. 7). Advantageously, heat staking could allow the film to permanently adhere to the sidewall without use of an adhesive. An adhesive may be problematic in some circumstances because it may release unwanted volatiles in the food- containing headspace. Aspects of a heat staking process that may be used in accordance with optional embodiments of the invention are disclosed in U.S. Pat. No. 8,142,603, as referenced above. Heat staking, in this instance, refers to heating a sealing layer substrate on the sidewall while exerting sufficient pressure on the film and sealing layer substrate to adhere the film to the container wall.
[0088] In certain embodiments, the antimicrobial entrained polymer film 114 may be connected to the surface of the lidding film 112 (or a lid) that is inside of the container, in place of the film sections 114 on the sidewall(s) 106, or in addition thereto. Alternatively, the antimicrobial entrained polymer film 114 may be incorporated into the composition of the lidding film 112 (or a lid). Optionally, the lidding film itself may include a lid barrier layer and an antimicrobial entrained polymer film layer beneath it.
[0089] In addition to placement of the film 114, another important factor is the release profile of the released antimicrobial material. As aforementioned, to ensure adequate shelf life, release of the agent must not all occur immediately; rather, release should be extended, sustained and predetermined to attain a desired shelf life.
[0090] In general, the polymer entrained with antimicrobial releasing agent is self activating, meaning that release of the released antimicrobial gas is not initiated until the antimicrobial releasing agent is exposed to the selected material, e.g., moisture. Typically,
moisture is not present in the interior, e.g., headspace, of the container prior to a food product being placed inside of the container. Upon placement, the food product generates moisture that interacts with the antimicrobial releasing agent entrained in the polymer, to generate the antimicrobial releasing agent in the headspace. In one embodiment, the container is sealed in a moisture tight manner to trap moisture within the container generated by moisture- exuding comestibles.
[0091] In certain embodiments, a controlled release and/or a desired release profile can be achieved by applying a coating to the active agent, e.g., using a spray coater, wherein the coating is configured to release the released antimicrobial agent within a desired time frame. The antimicrobial releasing agents may have different coatings applied thereon to achieve different release effects. For example, if a 14-day shelf life is desired, based on predetermined relative humidity of the package, the amount of selected material (moisture) present to trigger the antimicrobial releasing agent may be determined. Based on this determination, the agent may be coated with extended release coatings of varying thicknesses and/or properties to achieve the desired release profile. For example, some active agent will be coated such that it will not begin releasing released antimicrobial material until after one week, while other active agent will begin release almost immediately. Spray coating technology is known in the art. For example, pharmaceutical beads and the like are spray coated to control the release rate of active ingredient, e.g., to create extended or sustained release drugs. Optionally, such technology may be adapted to apply coatings to the active agent to achieve a desired controlled rate of release of antimicrobial gas.
[0092] Alternatively, a controlled release and/or desired release profile may be achieved by providing a layer, optionally on both sides of the film, of a material configured to control moisture uptake into the entrained polymer (which in turn triggers release of the released antimicrobial material). For example, the film may include a polymer liner, made e.g., from low density polyethylene (LDPE) disposed on either side or both sides thereof. The thickness of the film and liner(s) can vary. In certain embodiments, the film is approximately 0.3 mm thick and the LDPE liners on either side are each approximately 0.02 mm to 0.04 mm thick. The LDPE liners may be coextruded with the film or laminated thereon.
[0093] Alternatively, a controlled release and/or desired release profile may be achieved by modifying the formulation of the trigger of the antimicrobial releasing agent. For example, the trigger, when contacted by moisture, liquefies and then reacts with the active component (e.g., sodium chlorite) to cause release of the antimicrobial gas. The trigger may be formulated to liquefy upon contact with moisture at different rates. The faster the trigger liquefies, the faster the release of antimicrobial gas and vice versa. In this way, modification of the trigger is yet another vehicle provide a desired release rate of antimicrobial gas.
[0094] Any combination of the aforementioned mechanisms may be utilized to achieve desired release rates and release profiles of antimicrobial gas within a container headspace.
Varied Release Rates Depending on Nature of Stored Food Product
[0095] The inventors have discovered that the desired release profile of chlorine dioxide gas in a container headspace may vary depending on the nature of the product that is stored. For example, the inventors have found that foods having a high water content appear to require a high burst of antimicrobial gas followed by a drop in headspace concentration during the storage period while foods having a more modest water content appear to respond well to a relatively steady headspace concentration over the storage period.
[0096] Non-limiting examples of food products that exude high amounts of moisture and that are more appropriately protected by a release profile having a quick burst of chlorine dioxide gas followed by a drop include sliced, diced or cut foods selected from the group consisting of: tomatoes, washed peppers, washed onions, water melon, honey dew, cantaloupe, strawberries, peaches, pineapple, oranges, seafood, meat and poultry. For such foods, an amount of the antimicrobial releasing agent is provided that releases the chlorine dioxide gas to preferably provide a headspace concentration of from 6 parts per million (PPM) to 35 PPM for a period of 10 hours to 36 hours, optionally from 10 PPM to 35 PPM for a period of 16 to 36 hours, optionally from 15 PPM to 30 PPM for a period of 16 hours to 36 hours, optionally from 15 PPM to 30 PPM for a period of about 24 hours. Headspace concentration measurements may be obtained, for example, using a PORTASENS II gas detector from Analytical Technology, Inc. for readings taken with chlorine dioxide sensors placed within the package. The sensors may be one or more of 00-1004 Chlorine Dioxide,
0-1/5 PPM (2 PPM Std.), 00-1005 Chlorine Dioxide, 0-5/200 (20 PPM Std.) and 00-1359 Chlorine Dioxide, 0- 200/1000 PPM (1000 PPM Std.), which are also from Analytical Technology, Inc. and are compatible with the PORTASENS II gas detector.
[0097] This type of“quick burst” (e.g., headspace concentration of from 10 parts per million (PPM) to 35 PPM for a period of 16 hours to 36 hours) appears to be required so that the chlorine dioxide gas, which dissolves in water, can stay ahead of the dissolution curve to provide sufficient antimicrobial effect during the spike in headspace concentration, to improve the shelf life of contaminated food over an approximately two-week period. Notwithstanding the characterization of the release as “quick burst,” it may still be considered controlled release because headspace concentration is still regulated to fall within a desired concentration over a given period, even if relatively“quick.” The inventors have found, for example, that the aforementioned headspace concentrations works well to significantly reduce the microbial count of contaminated sliced tomatoes over about thirteen days without bleaching the tomatoes. This is borne out by examples provided below.
[0098] Non-limiting examples of food products that exude moderate or low amounts of moisture are whole or minimally processed produce selected from the group consisting of: broccoli, brussel sprouts, cabbage, cucumbers, bananas, herbs, whole peppers, carrots, root vegetables and potatoes. For such foods, an amount of antimicrobial releasing agent releases the chlorine dioxide gas to preferably provide a headspace concentration of from 8 PPM to 15 PPM for a period of 13 days. Regardless of whether this exact headspace concentration is met, it is preferred that the antimicrobial releasing agents are provided in entrained polymer films, as described herein, for such low or moderate moisture exuding foods.
[0099] The aforementioned release profiles and headspace concentration assume the presence of moisture exuding food product in the package.
[0100] In either case (high moisture exuding or moderate/low moisture exuding foods), where the product is contaminated by at least one type of pathogen, the chlorine dioxide gas is provided in a headspace concentration over a determined time period to effectuate, after a span of 2 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram
(CFU/g), optionally at least a 2 log base 10 reduction in CFU/g, optionally at least a 3 log base 10 reduction in CFU/g of the at least one type of pathogen, without substantially causing organoleptic degradation of the food product. Optionally, after a span of 4 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 2 log base 10 reduction in CFU/g, optionally at least a 3 log base 10 reduction in CFU/g, optionally at least a 4 log base 10 reduction in CFU/g of the at least one type of pathogen, without substantially causing organoleptic degradation of the food product. Optionally, after a span of 6 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 2 log base 10 reduction in CFU/g, optionally at least a 3 log base 10 reduction in CFU/g, optionally at least a 4 log base 10 reduction in CFU/g of the at least one type of pathogen, without substantially causing organoleptic degradation of the food product. Optionally, after a span of 10 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 2 log base 10 reduction in CFU/g, optionally at least a 3 log base 10 reduction in CFU/g, optionally at least a 4 log base 10 reduction in CFU/g of the at least one type of pathogen, without substantially causing organoleptic degradation of the food product. Optionally, after a span of 13 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 2 log base 10 reduction in colony forming units per gram (CFU/g), optionally at least a 3 log base 10 reduction in CFU/g, optionally at least a 4 log base 10 reduction in CFU/g of the at least one type of pathogen, without substantially causing organoleptic degradation of the food product. Such organoleptic degradation may include bleaching or other discoloration of the food product, as perceived by an ordinary consumer without special detection equipment.
[0101] Optionally, according to any embodiment, 700-950 mg of the antimicrobial releasing agent is effective when used in a 1L container having 1.25 lbs of tomatoes stored therein. It is contemplated that proportional adjustment of the mass of antimicrobial releasing agent
may be done according to changes in container volume and amount/type of contents.
Applications of Invention for Non-Edible Goods
[0102] In another aspect, the invention is directed to use of entrained polymers comprising antimicrobial agents for use outside of food preservation applications. For example, the solutions disclosed herein may be adapted for use in sterilization of disposable medical devices, i.e., to reduce the bioburden of such devices when they are packaged. The primary difference between preservation of fresh food and medical devices is shelf life. Preservation of fresh food implicates a shelf life measured in days or weeks while maintaining sterility of packaged medical devices requires a shelf life measured in months or years. Accordingly, the release profile over time for one application versus the other will necessarily vary.
Performance of Entrained Polymer
[0103] The performance of the entrained polymer of the current invention may be directly evaluated. The release of the CIO2 gas is triggered and initiated upon exposure to moisture, and the concentration of the released CIO2 gas in the headspace is measured over a period. Typically, the following two methods are used.
Method One.
[0104] A 2 g piece of the entrained polymer, for example, as a film, is placed in a 2.1 L mason jar as the testing chamber. In the mason jar is placed a piece of filter paper (110 mm diameter, Whatman, Cat # 1001-110) saturated with 1 mL purified water. Care is taken so that the film is placed where not in direct contact with the filter paper or the water thereon. The mason jar is sealed immediately with a lid. An environmental detectors (BW GasAlert CIO2) is then connected to and is in fluid communication with the headspace air via two ports in the lid. A gas transport line including an output line and a return line diverted the air in the headspace to the portable CIO2 gas analyzer before being returned. The CIO2 concentration is monitored.
Method Two
[0105] Method Two is identical to Method One in all aspects other than using a sponge (1’ x 1’ x ½’) instead of filter paper, and 10 mL water instead of 1 mL of water. Water (10 mL) is added to the sponge and is completely absorbed in the sponge to give no free water visibly. Method Two is used to induce a steeper decline of the CIO2 concentration due to the larger
amount of water in the chamber. The larger amount of free water available also reduces the concentration of the released CIO2 gas in the headspace.
[0106] Unless otherwise specified, the concentration of the released CIO2 gas referred to herein throughout is normalized to per gram of film, assuming the concentration of the released CIO2 gas is directly proportional to the amount of the entrained polymer film.
[0107] In one aspect, when evaluated using Method One or Method Two, the current invention provides an entrained polymer that provides CIO2 from 3 ppm to 1000 ppm, optionally 3 ppm to 800 ppm, optionally 3 ppm to 600 ppm, optionally 3 ppm to 500 ppm, optionally 3 ppm to 300 ppm, optionally 3 ppm to 200 ppm, optionally 3 ppm to 100 ppm, optionally 3 ppm to 50 ppm, optionally 10 ppm to 1000 ppm, optionally 10 ppm to 800 ppm, optionally 10 ppm to 600 ppm, optionally 10 ppm to 500 ppm, optionally 10 ppm to 300 ppm, optionally 10 ppm to 200 ppm, optionally 10 ppm to 100 ppm, optionally 10 ppm to 50 ppm, optionally 20 ppm to 1000 ppm, optionally 20 ppm to 800 ppm, optionally 20 ppm to 600 ppm, optionally 20 ppm to 500 ppm, optionally 20 ppm to 300 ppm, optionally 20 ppm to 200 ppm, optionally 20 ppm to 100 ppm, optionally 20 ppm to 50 ppm, optionally 30 ppm to 1000 ppm, optionally 30 ppm to 800 ppm, optionally 30 ppm to 600 ppm, optionally 30 ppm to 500 ppm, optionally 30 ppm to 300 ppm, optionally 30 ppm to 200 ppm, optionally 30 ppm to 100 ppm, optionally 30 ppm to 50 ppm, optionally 40 ppm to 1000 ppm, optionally 40 ppm to 800 ppm, optionally 40 ppm to 600 ppm, optionally 40 ppm to 500 ppm, optionally 40 ppm to 300 ppm, optionally 40 ppm to 200 ppm, optionally 40 ppm to 100 ppm, optionally 40 ppm to 50 ppm, optionally 60 ppm to 1000 ppm, optionally 60 ppm to 800 ppm, optionally 60 ppm to 600 ppm, optionally 60 ppm to 500 ppm, optionally 60 ppm to 300 ppm, optionally 60 ppm to 200 ppm, optionally 60 ppm to 100 ppm, optionally 100 ppm to 1000 ppm, optionally 100 ppm to 800 ppm, optionally 100 ppm to 600 ppm, optionally 100 ppm to 500 ppm, optionally 100 ppm to 300 ppm, optionally 100 ppm to 200 ppm, optionally 150 ppm to 1000 ppm, optionally 150 ppm to 800 ppm, optionally 150 ppm to 600 ppm, optionally 150 ppm to 500 ppm, optionally 150 ppm to 300 ppm, optionally 150 ppm to 200 ppm, optionally 200 ppm to 1000 ppm, optionally 200 ppm to 800 ppm, optionally 200 ppm to 600 ppm, optionally 200 ppm to 500 ppm, optionally 200 ppm to 300 ppm.
[0108] In one aspect, when evaluated using Method One or Method Two, the current invention provides an entrained polymer that normalized to a gram of entrained polymer provides at least 3 ppm of CIO2 1 hour after initiation, optionally, at least 10 ppm of CIO2 1 hour after initiation, optionally, at least 50 ppm of CIO2 1 hour after initiation, optionally, at least 100 ppm of CIO2 1 hour after initiation, optionally, at least 150 ppm of CIO2 1 hour after initiation, optionally, at least 300 ppm of CIO2 1 hour after initiation.
[0109] In one aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis provides at least 3 ppm of CIO25 hours after initiation, optionally, at least 10 ppm of CIO25 hours after initiation, optionally, at least 50 ppm of CIO25 hours after initiation, optionally, at least 100 ppm of CIO2 5 hours after initiation, optionally, at least 150 ppm of CIO2 5 hours after initiation, optionally, at least 300 ppm of CIO25 hours after initiation.
[0110] In one aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis provides at least 3 ppm of CIO2 12 hours after initiation, optionally, at least 10 ppm of CIO2 12 hours after initiation, optionally, at least 50 ppm of CIO2 12 hours after initiation, optionally, at least 100 ppm of CIO2 12 hours after initiation, optionally, at least 150 ppm of CIO2 12 hours after initiation, optionally, at least 300 ppm of CIO2 12 hours after initiation.
[0111] In one aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis provides at least 3 ppm of CIO2 24 hours after initiation, optionally at least 10 ppm of CIO2 24 hours after initiation, optionally, at least 50 ppm of CIO224 hours after initiation, optionally at least 100 ppm of CIO224 hours after initiation, optionally, at least 150 ppm of CIO224 hours after initiation, optionally at least 300 ppm of CIO224 hours after initiation.
[0112] In another aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis once reaches at least 3 ppm of CIO2, maintains the concentration of the CIO2 gas at at least 3 ppm for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0113] In another aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis once reaches at least 10 ppm of CIO2 , maintains the concentration of the CIO2 gas at at least 10 ppm for at least 6 hours, optionally for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0114] In another aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis once reaches at least 30 ppm of CIO2 , maintains the concentration of the CIO2 gas at at least 30 ppm for at least 6 hours, optionally for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0115] In another aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis once reaches at least 60 ppm of CIO2 , maintains the concentration of the CIO2 gas at at least 60 ppm for at least 6 hours, optionally for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0116] In another aspect, evaluated using Method One or Method Two, the current invention provides an entrained polymer that on a per gram of the entrained polymer basis once reaches at least 80 ppm of CIO2 , maintains the concentration of the CIO2 gas at at least 80 ppm for at least 6 hours, optionally for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0117] The invention provides an entrained polymer with varying features, such as a high peak concentration of the released CIO2 gas (for example, X-2719 through X-2723), a quick
release (for example, X-2706, X-2702, X-2696 through X-2699), and a sustained release (for example, X-2719 through X- 2723, X-2715, X-2713, X-2712, and X-2690). The invention provides an entrained polymer with the user’s desired release properties by varying the base polymer, channeling agent, releasing agent, and the weight proportions.
[0118] The entrained polymer of the current invention also enables the CIO2 gas released in a manner that after the initial release to effectuate antimicrobial effects produces no detectable headspace CIO2 gas. Further, no detectable levels of known CIO2 degradants (chlorite or chlorate) upon reaction with water or upon light exposure except for chloride. For example, in water, chlorine dioxide reacts quickly to form the very reactive chlorite ions which in turn are broken down to form chloride ions. In water, CIO2 could disproportionate to chlorite and chlorate. The entrained polymer of the current invention is capable of leaving no foot prints except for chloride. The phenomenon is particularly pronounced when the entrained polymer is used on a food product that provides an active redox environment. For example, tomatoes, oranges, apples, strawberries, and cantaloupe.
[0119] Without being bound to this theory, based on tests, observations and analysis, it is surmised that a two phase CIO2 gas releasing entrained polymer (without channeling agent) would provide insufficient peak and/or sustained concentration within a container headspace to provide desirable commercial efficacy. In other words, on a comparative weight basis, the two phase material would not appear to inhibit or prevent the growth of microbes and/or to kill microbes in or on a food product stored within the container, at least to practical levels. For example, the three phase (with channeling agent) entrained polymer according the disclosed concept may provide a peak and headspace concentration of CIO2 gas to effectuate, after a span of 2 days from when the product is provided within the interior space and under storage conditions of 7° C, at least a 1 log base 10 reduction in colony forming units per gram (CFU/g). It is surmised that such efficacy would not be readily achievable with a two phase material.
Recitation of Exemplary Embodiments
[0120] The following exemplary embodiments further describe optional aspects of the invention and are part of this Specification. These exemplary embodiments are set forth in a format substantially akin to claims (each with a numerical designation followed by a letter
designation), although they are not technically claims of the present application. The following exemplary embodiments refer to each other in dependent relationships as “embodiments” instead of“claims.”
[0121] 1A. An entrained polymer comprising:
a. a base polymer;
b. a chlorine dioxide gas releasing agent; and
c. a channeling agent,
wherein the entrained polymer features channels though the entrained polymer formed of the channeling agent,
wherein the chlorine dioxide gas releasing agent comprises a chlorite salt,
and wherein the entrained polymer on a per gram basis releases the chlorine dioxide gas in a concentration of 3 ppm to 1000 ppm, optionally 10 ppm to 1000 ppm, optionally 30 ppm to 1000 ppm, optionally 60 ppm to 1000 ppm, optionally 100 ppm to 1000 ppm, optionally 10 ppm to 800 ppm, optionally 30 ppm to 600 ppm, optionally 60 ppm to 600 ppm, optionally 100 ppm to 500 ppm, wherein chlorine dioxide gas release is initiated and the concentration of the chlorine dioxide gas is measured using Method One or Method Two.
[0122] 2A. The entrained polymer of claim 1A, wherein the entrained polymer releases the chlorine dioxide gas in a concentration of at least 3 ppm, optionally at least 10 ppm, optionally at least 30 ppm, optionally at least 50 ppm, optionally at least 100 ppm, optionally at least 150 ppm, or optionally at least 300 ppm, 1 hour after initiation.
[0123] 3A. The entrained polymer of 1A or 2A, wherein the entrained polymer releases the chlorine dioxide gas in a concentration of at least 3 ppm, optionally at least 10 ppm, optionally at least 30 ppm, optionally at least 50 ppm, optionally at least 100 ppm, optionally at least 150 ppm, or optionally at least 300 ppm, 5 hours after initiation.
[0124] 4A. The entrained polymer of any of embodiments 1A to 3A, wherein the entrained polymer releases the chlorine dioxide gas in a concentration of at least 3 ppm, optionally at least 10 ppm, optionally at least 30 ppm, optionally at least 50 ppm, optionally at least 100 ppm, optionally at least 150 ppm, or optionally at least 300 ppm, 12 hours after initiation.
[0125] 5A. The entrained polymer of any of embodiments 1A to 4A, wherein the
entrained polymer releases the chlorine dioxide gas in a concentration of at least 3 ppm, optionally at least 10 ppm, optionally at least 30 ppm, optionally at least 50 ppm, optionally at least 100 ppm, optionally at least 150 ppm, or optionally at least 300 ppm, 24 hours after initiation.
[0126] 6A. The entrained polymer of any of embodiments 1A to 5A, wherein after the concentration of the chlorine dioxide gas reaches at least 3 ppm, the concentration is maintained for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0127] 7A. The entrained polymer of any of embodiments 1A to 6A, wherein after the chlorine dioxide gas reaches a concentration of at least 10 ppm, maintains the concentration for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0128] 8A. The entrained polymer of any of embodiments 1A to 7A, wherein after the chlorine dioxide gas reaches a concentration of at least 30 ppm, maintains the concentration for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0129] 9A. The entrained polymer of any of embodiments 1A to 8A, wherein after the chlorine dioxide gas reaches a concentration of at least 50 ppm, maintains the concentration for at least 12 hours, optionally for at least 24 hours, optionally for at least 36 hours, optionally for at least 48 hours, optionally for at least 60 hours, optionally for at least 72 hours, optionally for at least 84 hours, optionally for at least 96 hours.
[0130] 10A. The entrained polymer of any of embodiments 1 A to 9A, wherein the chlorine dioxide gas releasing agent is from 10% to 80%, optionally 30% to 70%, optionally 30% to 60%, optionally 30% to 50%, optionally from 35% to 70%, optionally from 35% to 60%, optionally from 35% to 55%, optionally from 35% to 50%, optionally 40% to 70%, optionally from 40% to 60%, optionally from 40% to 50%, optionally from 45% to 60%, optionally from 50% to 60% by weight of the entrained polymer.
[0131] 11 A. The entrained polymer of any of embodiments 1A to 10A, wherein the channeling agent may be provided in from 1% to 16%, optionally from 1% to 14%, optionally from 1% to 12%, optionally from 1% to 10%, optionally from 1% to 8%, optionally from 1% to 6%, optionally from 1% to 5%, optionally from 1% to 4%, preferably from 2% to 16%, optionally from 2% to 14%, optionally from 2% to 12%, optionally from 2% to 10%, optionally from 2% to 8%, optionally from 2% to 6%, optionally from 2% to 5%, optionally from 2% to 4%, optionally from 4% to 12%, optionally from 4% to 10%, optionally from 4% to 8%, optionally from 4% to 6%, optionally from 4% to 5%, optionally from 6% to 12%, optionally from 6% to 10%, optionally from 6% to 8%, optionally from 8% to 12%, optionally from 8% to 10% by weight of the entrained polymer.
[0132] 12A. The entrained polymer of any of embodiments 1A to 11 A, wherein the base polymer may range from 10% to 70%, optionally from 10% to 60%, optionally from 10% to 50%, optionally from 10% to 40%, optionally from 20% to 60%, optionally from 30% to 70%, optionally from 30% to 60%, from 30% to 50%, optionally from 40% to 70%, optionally from 40% to 60%, from 40% to 50% by weight of the total composition.
[0133] 13A. The entrained polymer of any of embodiments 1 A to 12A, wherein the at least one entrained polymer is provided as a film having a thickness of from 0.1 mm to 1.0 mm, preferably from 0.2 mm to 0.6mm, optionally about 0.3 mm.
[0134] 14A. The entrained polymer of any of embodiments 1A to 13A, wherein the channeling agent is a polyglycol, ethylene-vinyl alcohol (EVOH), polyvinyl alcohol (PVOH), glycerin polyamine, polyurethane, polycarboxylic acid, a propylene oxide polymerisate-monobutyl ether, a propylene oxide polymerisate monobutyl ether, propylene oxide polymerisate, ethylene vinyl acetate, nylon 6, nylon 66, vinylpyrrolidone-vinyl acetate copolymer 60/40 (PVPVA 64), or a combination thereof.
[0135] 15A. The entrained polymer of any of embodiments 1A to 13A, wherein the channeling agent is a polyglycol, vinylpyrrolidone-vinyl acetate copolymer 60/40 (PVPVA 64), or a combination thereof.
[0136] 16A. The entrained polymer of any of embodiments 1A to 15A, wherein the chlorine dioxide gas releasing agent further comprises a catalyst and a moisture trigger.
[0137] 17A. The entrained polymer of any of embodiments 1A to 16A, wherein the base
polymer is thermoplastic polymers, e.g., polyolefins such as polypropylene and polyethylene, polyisoprene, polybutadiene, polybutene, polysiloxane, polycarbonates, polyamides, ethylene-vinyl acetate copolymers, ethylene- methacrylate copolymer, poly(vinyl chloride), polystyrene, polyesters, polyanhydrides, polyacrylonitrile, polysulfones, polyacrylic ester, acrylic, polyurethane and polyacetal, or copolymers or mixtures thereof.
[0138] 18A. The entrained polymer of any of embodiments 1A to 17A, wherein the base polymer is 10% to 70%, optionally from 10% to 60%, optionally from 10% to 50%, optionally from 10% to 40%, optionally from 30% to 70%, optionally from 30% to 60%, from 30% to 50%, optionally from 40% to 70%, optionally from 40% to 60%, from 40% to 50% by weight of the entrained polymer.
[0139] 19A. The entrained polymer of any of embodiments 1A to 18A, wherein the chlorine dioxide releasing agent is 10% to 80%, optionally 30% to 70%, optionally 30% to 60%, optionally 30% to 50%, optionally from 35% to 70%, optionally from 35% to 60%, optionally from 35% to 55%, optionally from 35% to 50%, optionally 40% to 70%, preferably from 40% to 60%, optionally from 40% to 50%, optionally from 45% to 60%, optionally from 50% to 60% by weight of the entrained polymer.
[0140] 20A. The entrained polymer of any of embodiments 1A to 19A, wherein the channeling agent is 1% to 16%, optionally 1% to 14%, optionally 1% to 12%, optionally from 1% to 10%, optionally from 1% to 8%, optionally from 1% to 6%, optionally from 1% to 5%, optionally from 1% to 4%, optionally from 2% to 16%, optionally from 2% to 14%, optionally from 2% to 12%, optionally from 2% to 10%, optionally from 2% to 8%, optionally from 2% to 6%, optionally from 2% to 5%, optionally from 2% to 4%, optionally from 4% to 12%, optionally from 4% to 10%, optionally from 4% to 8%, optionally from 4% to 6%, optionally from 4% to 5%, optionally from 6% to 12%, optionally from 6% to 10%, optionally from 6% to 8%, optionally from 8% to 12%, optionally from 8% to 10% by weight of the entrained polymer
[0141] IB. A package for inhibiting or preventing growth of microbes and/or for killing microbes in a closed container, comprising the entrained polymer of any of embodiments 1A to 16 A,
[0142] 2B. The package of IB, wherein a product is provided within an interior space, the product is contaminated by at least one type of pathogen.
[0143] 3B. The package of embodiments IB or 2B, wherein the chlorine dioxide gas in the headspace is detectable from the time of initiation only up until 16 hours, optionally only up until 20 hours, optionally only up until 24 hours, optionally only up until 36 hours, optionally only up until 48 hours (i.e., the CIO2 is undetectable after those points in time).
[0144] 1C. A method for inhibiting or preventing the growth of microbes and/or for killing microbes in a container, the method comprising providing the entrained polymer of any of embodiments 1A to 16 A, in an interior space of the container.
[0145] ID. A method for inhibiting or preventing the growth of microbes and/or for killing microbes in a closed container, the method comprising:
a. providing a closed container defining an interior space therein;
b. providing a food product within the interior space wherein a headspace is formed within a volume of the interior space that is not occupied by the food product; and c. providing within the interior space an entrained polymer article that is a monolithic material comprising a base polymer, a channeling agent and an antimicrobial releasing agent comprising a chlorite salt, the antimicrobial releasing agent being configured to release chlorine dioxide gas upon activation by moisture that is exuded by the food product and/or rests upon the food product;
wherein the chlorine dioxide gas is released into the headspace to achieve a peak concentration and sustained concentration within the headspace sufficient to inhibit or prevent the growth of microbes and/or for killing microbes in or on the food product, optionally wherein the chlorine dioxide gas in the headspace is detectable from the time of initiation only up until 16 hours, optionally only up until 20 hours, optionally only up until 24 hours, optionally only up until 36 hours, optionally only up until 48 hours (i.e., the CIO2 is undetectable after those points in time).
[0146] IE. A method of generating chlorine dioxide gas to reach a peak concentration within an enclosure and then maintain a sustained concentration range within the enclosure for a desired time period, the method comprising:
a. providing an entrained polymer article that is a monolithic material comprising a base
polymer, a channeling agent and an antimicrobial releasing agent comprising a chlorite salt, the antimicrobial releasing agent being configured to release chlorine dioxide gas upon activation by moisture; and
b. providing a source of moisture within the enclosure, optionally a moisture-exuding food product, within the enclosure, which is configured to activate the antimicrobial releasing agent;
wherein peak concentration of at least 6 ppm, optionally at least 10 ppm, optionally at least 15 ppm, is achieved after 3 hours post-initiation and a concentration of at least 3ppm or at least 6 ppm is maintained for up until 16 hours, optionally up until 20 hours, optionally up until 24 hours, optionally up until 36 hours post-initiation.
[0147] IF. A method of generating chlorine dioxide gas to reach a peak concentration within an enclosure and then maintain a sustained concentration range within the enclosure for a desired time period, the method comprising:
a. providing an entrained polymer article that is a monolithic material comprising a base polymer, a channeling agent and an antimicrobial releasing agent comprising a chlorite salt, the antimicrobial releasing agent being configured to release chlorine dioxide gas upon activation by moisture; and
b. providing a source of moisture within the enclosure which is configured to activate the antimicrobial releasing agent;
wherein the entrained polymer on a per gram basis achieves a chlorine dioxide gas concentration of at least 25 ppm after 1-3 hours post-initiation and wherein afterwards the chlorine dioxide gas concentration remains at at least 25 ppm until at least 12 hours, optionally at least 24 hours, optionally at least 36 hours, optionally at least 48 hours, optionally at least 60 hours, optionally at least 72 hours post-initiation under either of the following test conditions:
i. a 2 g piece of the entrained polymer is placed in a 2.1 L mason jar where a piece of filter paper saturated with 1 mL water is placed such that the filter paper is not in direct contact with the entrained polymer, the mason jar being enclosed by a lid; or
ii. a 2 g piece of the entrained polymer is placed in a 2.1 L mason jar where a sponge that has absorbed 10 mL water is placed within the mason jar such that the sponge is not in
direct contact with the entrained polymer, the mason jar being enclosed by a lid.
[0148] 2F. The method of embodiment IF, wherein the entrained polymer on a per gram basis achieves a chlorine dioxide gas concentration of at least 50 ppm after 1-3 hours post initiation and wherein afterwards the chlorine dioxide gas concentration remains at at least 25 ppm until until at least 12 hours, optionally at least 24 hours, optionally at least 36 hours, optionally at least 48 hours, optionally at least 60 hours, optionally at least 72 hours post initiation.
[0149] 3F. The method of embodiment IF or 2F, wherein the entrained polymer on a per gram basis achieves a chlorine dioxide gas concentration of at least 100 ppm after 1-3 hours post-initiation and wherein afterwards the chlorine dioxide gas concentration remains at at least 25 ppm until at least 12 hours, optionally at least 24 hours, optionally at least 36 hours, optionally at least 48 hours, optionally at least 60 hours, optionally at least 72 hours post initiation.
[0150] 1G. A method of generating chlorine dioxide gas to reach a peak concentration within an enclosure and then maintain a sustained concentration range within the enclosure for a desired time period, the method comprising:
a. providing an entrained polymer article that is a monolithic material comprising a base polymer, a channeling agent and an antimicrobial releasing agent comprising a chlorite salt, the antimicrobial releasing agent being configured to release chlorine dioxide gas upon activation by moisture; and
b. providing a source of moisture within the enclosure which is configured to activate the antimicrobial releasing agent;
wherein the entrained polymer on a per gram basis achieves a chlorine dioxide gas concentration of at least 25 ppm after 3-6 hours post-initiation and wherein afterwards the chlorine dioxide gas concentration remains at at least 25 ppm until at least 12 hours, optionally at least 24 hours, optionally at least 36 hours, optionally at least 48 hours, optionally at least 60 hours, optionally at least 72 hours post-initiation under either of the following test conditions:
i. a 2 g piece of the entrained polymer is placed in a 2.1 L mason jar where a piece
of filter paper saturated with 1 mL water is placed such that the filter paper is not in direct contact with the entrained polymer, the mason jar being enclosed by a lid; or
ii. a 2 g piece of the entrained polymer is placed in a 2.1 L mason jar where a sponge that has absorbed 10 mL water is placed within the mason jar such that the sponge is not in direct contact with the entrained polymer, the mason jar being enclosed by a lid.
[0151] 2G. The method of embodiment 1G, wherein the entrained polymer on a per gram basis achieves a chlorine dioxide gas concentration of at least 50 ppm after 3-6 hours post initiation and wherein afterwards the chlorine dioxide gas concentration remains at at least 25 ppm until at least 12 hours, optionally at least 24 hours, optionally at least 36 hours, optionally at least 48 hours, optionally at least 60 hours, optionally at least 72 hours post initiation.
[0152] 3G. The method of embodiment 1G or 2G, wherein the entrained polymer on a per gram basis achieves a chlorine dioxide gas concentration of at least 100 ppm after 3-6 hours post-initiation and wherein afterwards the chlorine dioxide gas concentration remains at at least 25 ppm until until at least 12 hours, optionally at least 24 hours, optionally at least 36 hours, optionally at least 48 hours, optionally at least 60 hours, optionally at least 72 hours post-initiation.
[0153] 4A. A method for inhibiting or preventing the growth of microbes and/or for filling microbes in a closed container, the method comprising:
a. providing a closed container defining an interior space therein;
b. providing a food product within the interior space wherein a headspace is formed within a volume of the interior space that is not occupied by the food product; and
c. providing within the interior space an entrained polymer article that is a monolithic material comprising a base polymer, a channeling agent and an antimicrobial releasing agent comprising a chlorite salt, the antimicrobial releasing agent being configured to release chlorine dioxide gas upon activation by moisture that is exuded by the food product and/or rests upon the food product;
wherein the chlorine dioxide gas is released into the headspace to achieve a peak concentration and sustained concentration within the headspace sufficient to inhibit or
prevent the growth of microbes and/or for killing microbes in or on the food product.
[0154] The invention will be illustrated in more detail with reference to the following Examples, but it should be understood that the present invention is not deemed to be limited thereto.
EXAMPLES
Example 1 - Controlling Release of 002 Gas
[0155] A storage temperature of 7° C was chosen to replicate a storage temperature that is slightly elevated above ideal storage temperature (or to stimulate an inadvertent spike in temperature during storage, e.g., when refrigeration equipment breaks down for a few hours). Three packages similar to that shown in FIG. 7 were utilized in this experiment. All three included antimicrobial entrained polymer film sections placed substantially as shown in FIG. 7. The film was a three phase entrained polymer film including an antimicrobial releasing agent in the form of a powdered mixture comprising sodium chlorite (which produces chlorine dioxide gas), sulfuric acid clay (as a catalyst) and calcium chloride (as a humidity trigger). This powdered mixture is sold commercially by BASF under the name ASEPTROL and is described above.
[0156] The formulation for the film itself was a three phase formulation including 50% by weight of the aforementioned antimicrobial releasing agent in the form of the powdered mixture, 38% by weight ethyl vinyl acetate (EVA) as a base polymer and 12% by weight polyethylene glycol (PEG) as a channeling agent. This film formulation is described herein as X2597 and is considered one exemplary non-limiting embodiment of an entrained polymer according to an aspect of the disclosed concept. As described above, the antimicrobial releasing agent is triggered by moisture to release chlorine dioxide (C102) gas as the released antimicrobial material. The film, as between the three packages, was the same formulation and dimensions. However, two of the films had external layers to control moisture uptake and one had no such layers. The film in Package A was sandwiched between coextmded layers of LDPE that were about 0.02 mm thick. The film in Package B was sandwiched between coextmded layers of LDPE that were about 0.04 mm thick. The film in Package C (the control) had no such polymer layers on either side of the film.
[0157] The 002 levels in the packages were measured for 13 days with detection sensors calibrated for the desired concentration known to have an antimicrobial effect on most organisms. Results were as follows (values presented in ppm concentration of 002).
[0158] This Example demonstrates that Package B had the steadiest and most consistent release profile, attributable to the thicker polymer liner sandwiching the antimicrobial film, which controlled moisture uptake into the film. The release profile of Package B may be desirable for certain applications, for example, where the food product exudes a relatively modest amount of moisture, such as broccoli.
Example 2 - Geotrichum Growth Testing
[0159] A common cause of rejects for quality of tomatoes is Geotrichum candidum, a yeast like mold that grows as a white fuzz. In this example, sliced tomatoes deliberately tainted with G. candidum were packaged and subjected to testing. A storage temperature of 7° C was chosen to replicate a storage temperature that is slightly elevated above ideal storage temperature (or to stimulate an inadvertent spike in temperature during storage, e.g., when refrigeration equipment breaks down for a few hours).
[0160] A package similar to that shown in FIG. 7, with the C102-releasing antimicrobial film placed towards the top of the package, was used to store the contaminated sliced tomatoes.
A second package, otherwise identical to the first except without the antimicrobial film, was used to store the contaminated sliced tomatoes. The results are provided on the graphs shown in FIGS. 8 A and 8B. The results show conclusively that the antimicrobial film significantly inhibited growth of Geotrichum on the sliced tomatoes compared to the package without the film. In the package without the antimicrobial film, proliferation of Geotrichum on the sliced tomatoes was readily apparent to the naked eye. By contrast, the sliced tomatoes in the package with the entrained polymer C102-releasing antimicrobial film appeared fresh, with no visible signs of Geotrichum growth. This is further notable given the suboptimal 7° C storage conditions for the 14-day test.
[0161] It should be understood that examples on tomatoes were merely exemplary and that other produce and fresh foods (e.g., meat) may be used in accordance with the invention. It should be further understood that while chlorine dioxide is one preferred released antimicrobial material, other released antimicrobial materials are within the scope of the invention and may be preferred for other applications.
Example 3 - Antimicrobial Film Location Testing
[0162] Entrained polymer film (X2597 film, described above) was placed in the headspace of a tray at various height positions on the sidewalls to test the effectiveness of various antimicrobial film locations/positions, as well as various sampling locations. The abbreviation“MCT” as used herein refers to Maxwell Chase Technologies, LLC of Atlanta, GA. The abbreviation “FPT” refers to FRESH-R-PAX® trays of Maxwell Chase Technologies, LLC.
[0163] The following materials were used in this example:
[0164] The MCT FPT125D (1/4 steam size, deep white polypropylene) trays were modified as follows. Three holes approximately 8.5 mm wide and 2 cm apart were made into the MCT FPT125D trays with an Xacto knife. Edges of the hole were cleaned and the CPC valves were screwed into the holes with an o-ring on both sides, and the compression fitting tightening down the 2 rings. Both valves were placed with QDV on the outside of the lid and container to allow for the automatic closing valves to be on the outside for sampling purposes.
[0165] Flex® GP 70 3/16” ID, ¼” OD black PVC tubing(MCM#5231K35) was used on both intake and outtake ports of the C16 Portable Gas Analyzer, as well as the other end of
the CPC #3438400 Quick-Disconnect Valves with compression fittings to connect to the trays to sample the headspace in the trays.
[0166] CSP film samples were cut from the same strip of film and same width. Then, each sample was weighed to 1.000 g and connected to a sidewall of the tray with a plastic piece to hold it in place. There were two samples in each tray, which resulted in 2 g of CSP film per tray. Each of the samples was connected to a different sidewall of the tray.
[0167] The tomatoes were sliced using the hand-slicer with the calyx facing down. The ends were discarded. About 7 slices of tomatoes were placed on the bottom surface of each tray.
[0168] The manual sealer was heated to 375°F, and each tray with tomatoes therein was placed on the respective sealing plate. Lidding/Sealing film was placed over the tray, the sealing handle was pressed down and held for approximately 1-2 seconds to cover/seal the tomatoes inside the tray.
[0169] For each of the trays, the C102 release rate was measured in one -hour intervals over an 11-hour period. FIG. 9 shows the release of 002 (ppm) corresponding to various positions of the CSP film in the tray, i.e., at 0%, 50%, 64%, 79% and 100% height from the bottom surface based on total height of the sidewall. These respective heights are measured from the midline of the film. FIG. 10 shows the effect of the CSP film height on headspace concentration.
[0170] The results indicate that varying the height of the CSP film in the tray has an effect on the presence of 002 in the headspace. From the bottom of the tray (0%) to the mid-point (50%- approximately 2 inches up the sidewall in this particular non-limiting example), there was only a small, e.g., insignificant change in headspace concentration. However, from the mid-point to the top of the tray, the increase in height resulted in a significant increase in concentration. The concentration doubled from a position at 64% of the total height to the top of the tray (100%). The data indicates that in order to maximize the headspace concentration of C102 for optimum effectiveness and/or to minimize the amount of film required, the placement of the film should be preferably in the top 20% of the tray, i.e., positioned at a vertical height that is 80% to 100% of the total height of the sidewall measured from the bottom surface, and should be placed at least at 64% of the total
height of the sidewall of the tray.
Example 4 - Use of Quick Burst Release Profiles to Kill Pathogens
[0171] The effectiveness of reducing the level of Listeria monocytogenes, E. coli, and Salmonella, was evaluated for CSP 002 film applied to an upper portion of a tray as compared to control trays absent of the CSP C102 film.
[0172] CSP C102 emitting films, designated formulation X2597 (described above), at 0.3 mm thickness were used. This formulation was designed to have a fast 002 release profile and did not use an overlying polyethylene layer to reduce the moisture uptake rate into the film. As described above, the X-2597 film is a three phase formulation including 50% by weight of antimicrobial releasing agent , 38% by weight ethyl vinyl acetate (EVA) as a base polymer and 12% by weight polyethylene glycol (PEG) as a channeling agent. Trays with either 4 grams or 3 grams of film per tray were used. The tomatoes in the tray were each inoculated with three pathogens, i.e., Listeria monocytogenes, E. Coli and Salmonella.
[0173] The following materials were used in this example.
[0174] Salmonella, Listeria monocytogenes, and E. Coli 0157:H7 5 strain cocktails were prepared, mixed and kept overnight. The target was to achieve a 5-log inoculation of each
9
pathogen on the tomatoes. The inoculated tomatoes had 10 CFU pathogen/ml inoculum. Inoculations were plated for verification and initial levels.
[0175] A solution of 200 ppm free chlorine solution was prepared using lukewarm water. The slicer was immersed in the solution for 2 min, and then rinsed with tap water.
[0176] A 200-ppm free chlorine solution was prepared using warm water (approximately the same temperature as for the tomatoes). The tomatoes were placed in tap water first, then the chlorine solution for 2 minutes, and rinsed with tap water. The tomatoes were sliced using the hand-slicer with the calyx facing down. The ends were discarded such that there were 42 slices packed into each tray (6 tomatoes by 7 slices/tomato).
[0177] Eighteen (18) tomato slices within each tray were spot inoculated with the Salmonella, Listeria monocytogenes, and E. Coli (6 each) inoculums to achieve a triplicate analysis in each tray. The 18 tomato slices selected were identified by marking each slice with a Sharpie adjacent to the area to be inoculated. The inoculum was vortexed and 10 m 1 of inoculum was quickly withdrawn with a sterile pipette tip and micro pipetted onto the two slices marked at the top. This was repeated twice more per tray per pathogen.
[0178] The manual sealer was heated to 375°F. Each tray was placed on the sealing plate and the lidding film was pulled over the tray. The sealing handle was depressed and held in place for approximately 1-2 seconds. After sealing, each tray was checked to verify that the lidding film was fully attached to the tray.
[0179] The test trays were analyzed on days 0, 5, 8 and 12. For each tray, there were a total of three samples for each pathogen, three pathogens per tray and three APC (aerobic plate count) samples were taken from each tray. Each sample consisted of two slices taken using sterile forceps. The two slices were weighed into the sterile stomacher bag (weight was approximately 40-50 g) and three times the amount of sterile Peptone water was added. The tomatoes were stomached at 260 rpm for 1 minute. The necessary dilutions were then
prepared (~3) from the homogenate and duplicate spread plated onto the corresponding PC A, MOX, SMAC, or XLD plates.
[0180] Data was calculated as colony forming units (CFU) per gram. CFU values were converted to log values for data analysis. Data was averaged per tray and per sample type. The following is a summary of the tests that were conducted on respective days. The term “CSP3” refers to trays using 3g of X2597 film and the term“CSP4” refers to trays using 4g of X2597 film.
[0181] Day 0: 1 MCT tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 12 tests; 1 CSP4 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 12 tests; 1 CSP3 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 12 tests; 1 UN tray not inoculated (Negative Control) x 4 tests (sal, E.coli,Lm,APC)/tray = 4 tests. Cumulatively, this was a total of 40 tests.
[0182] Day 5: 3 MCT tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 3 CSP4 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 3 CSP3 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 1 UN tray not inoculated (Negative Control) x 4 tests (sal, E.coli,Lm,APC)/tray = 4 tests. Cumulatively, this was a total of 112 tests.
[0183] Day 8: 3 MCT tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 3 CSP4 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 3 CSP3 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 1 UN tray not inoculated (Negative Control) x 4 tests (sal, E.coli,Lm,APC)/tray = 4 tests. Cumulatively, this was a total of 112 tests.
[0184] Day 12: 3 MCT tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 3 CSP4 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 3 CSP3 tray inoculated w/ 3 Salmonella, 3 E. Coli, 3 Listeria and 3 APC tests/tray = 36 tests; 1 UN tray not inoculated (Negative Control) x 4 tests (sal, E.coli,Lm,APC)/tray = 4 tests. Cumulatively, this was a total of 112 tests.
[0185] In all, this experiment cumulatively included a total of 376 tests (94 Salmonella, 94 E. Coli, 94 Listeria, 94 APC). Results are shown in FIGS. 11-13.
[0186] FIG. 11 shows that there was a decline in Salmonella after Day 0 and stayed in
decline until day 12 for the CSP3 trays, and continued for the CSP4 trays. Each of these samples showed a reduction in Salmonella counts of at least 1.8 logs on day 5, 2.5 logs for day 8, and 3 logs for Day 12 respectively. This demonstrates a 99.9% reduction in Salmonella after 12 days in the CSP trays.
[0187] FIG. 12 shows results for E. coll that are similar to the Salmonella results. A decline in E. coll after Day 0 resulted in a reduction of at least 2 logs on day 5, 4 logs on day 8, and 3 logs on day 12. Similar to FIG. 11 for Salmonella , FIG. 12 shows an increase for the CSP3 tray on Day 12. It was determined that there was a 99.9% reduction in E. coll after a 12-day period.
[0188] FIG. 13 shows that the CSP film also reduced Listeria by 1 log over 12 days of shelf life. This is consistent on every day samples were obtained, and demonstrated a 90% reduction of Listeria monocytogenes consistently for 12 days.
[0189] These results demonstrate the effectiveness of the CSP trays (according to optional aspects of the invention) with sliced tomatoes over a 12-day storage period to reduce the amounts of Salmonella , E. coli, and Listeria inoculated on the tomato slices and stored at 8°C. This is not a normal storage condition, but it simulates potential abuse within the cold chain that is noted in food safety storage practices as being the major cause of spoilage and pathogen growth. The use of these trays can contribute to reducing the potential for pathogens growth to harmful levels in sliced tomatoes.
Example 5 - Quick Burst Antimicrobial Gas Release Curves
[0190] As described in Example 4, above, trays using 3g or 4g of X2597 film demonstrated significant activity in inhibiting pathogenic growth and proliferation over the testing period. The film formulations were configured to provide a quick burst release profile, as discussed elsewhere in this specification. FIG. 14 provides release curves for the 3g and 4g versions that were used in Example 4. FIG. 14 also provides a release curve for trays that used only 2g of film.
[0191] As FIG. 14 shows, the trays using 4g of film (CSP4) peaked at approximately 30 ppm of C102 at about hour 18, while holding above 10 ppm between about hour 6 to hour 33. The trays using 3g of film (CSP3) peaked at approximately 23 ppm of C102 at about hour 15,
while holding above 10 ppm between about hour 6 to hour 33. As stated above in Example 4, these embodiments provided sufficient headspace concentration to achieve a desired microbial kill and did so without bleaching the tomatoes.
[0192] FIG. 14 also shows a release curve for trays using 2g of film. As the curve shows, that embodiment peaked at approximately 16 ppm of 002 between hours 12 and 18. However, that curve shows that 002 concentration only held above 10 ppm between about hours 8 to 26. In some circumstances, this concentration and release curve may provide sufficient antimicrobial effect, but in this instance, this concentration was not preferred (albeit is still within the scope of optional aspects of the disclosed concepts).
Example 6 - Representative Antimicrobial Films of the Invention
[0193] Thirty-eight types of antimicrobial film were extruded (0.3 mm in thickness) according to the formulations in Tables 1-5 below. The prefix X to each batch number is omitted in the tables below. Therefore, a batch number 2719 may also be referred to as X-
2719.
Table 1. Formulation of films with Batch Numbers 2719-2726.
Table 2. Formulation of films with Batch Numbers 2711-2718.
Table 3. Formulation of films with Batch Numbers 2703-2708.
Table 4. Formulation of films with Batch Numbers 2695-2702.
Table 5. Formulation of films with Batch Numbers 2687-2694.
Example 7 - Antimicrobial Films with Wide Range of Gas Release Properties
[0194] The release of the CIO2 gas from the films in Example 6 was triggered and measured using Method One or Method Two as described above. For example, using Method One, a 2 g piece of each of the films in Example 6 was placed in a 2.1 L mason jar. In the mason jar was placed a piece of filter paper (110 mm diameter, Whatman, Cat # 1001-110) containing 1 mL purified water. Care was taken so that the film was not in direct contact with the filter paper or the water thereon. The mason jar was sealed immediately with a lid. An environmental detectors (BW GasAlert CIO2) was connected to and was in fluid communication with the headspace air via two ports in the lid. The CIO2 concentration was monitored.
[0195] The results of the released CIO2 concentration using Method Two are tabulated in Tables 6-11 and plotted in FIG. 15 (corresponding to films in Table 1 and data in Table 6), FIG. 16 (corresponding to films in Table 2 and data in Table 7), FIG. 17 (corresponding to films in Table 3 and data in Table 8 and 9), FIG. 18 (corresponding to films in Table 4 and data in Table 10), and FIG. 19 (corresponding to films in Table 5 and data in Table 11) respectively.
[0196] These examples represent embodiments of the current invention that provide varying features, such as a high peak concentration of the released CIO2 gas (for example, X-2719
through X-2723), a quick release (for example, X-2706, X-2702, X-2696 through X-2699), and a sustained release (for example, X-2719 through X-2723, X-2715, X-2713, X-2712, and X-2690).
[0197] The base polymers, channeling agents, and the chlorine dioxide releasing agents described above provides an entrained polymer that affords the user a desired release profile.
[0198] The preferred embodiments can be found in X-2719 through X-2723, X-2706, X- 2702, X-2695 through X-2699, X-2719 through X-2723, X-2712 through X-2715, and X- 2689 through X-2692, and the make-up thereof.
Table 6. Headspace concentration of released chlorine dioxide.
Table 7. Headspace concentration of released chlorine dioxide.
' An average of three samples for each time point is reported with the exception of the last four time points (one sample for each).
Table 8. Headspace concentration of released chlorine dioxide.
Table 9. Headspace concentration of released chlorine dioxide.
' An average of three samples for each time point is reported with the exception of the last four time points (one sample for each).
Table 10. Headspace concentration of released chlorine dioxide.
Table 11. Headspace concentration of released chlorine dioxide.
Example 8 - Superior Release Results of Invention
[0199] Films X-2596 and X-2597 were extruded according to the formulation below. Note that X-2597 and X-2702 share the same composition.
[0200] The release properties of Films X-2596 and X-2597 were evaluated using Method One described above. The released CIO2 concentration for each is shown in the table below (normalized to per gram of film) and is plotted in FIG. 20.
'An average of three samples for each time point is reported
[0201] In a separate evaluation of Films X-2596 and X-2597 using Method One, the CIO2 gas release was monitored during a period of 10 hrs after initiation to 13 hrs after initiation. The concentration of the released CIO2 concentration from Films X-2597 was steady while no released CIO2 from Films X-2596 was detected.
[0202] Additionally, Film X-2597 routinely provides a peak concentration of the released CIO2 gas at about 1000 ppm under the Method One conditions. The following table represents the release profile of the entrained polymer film X-2597.
Example 9 - Degradant Analysis
[0203] Packages in Example 2 shown in FIG. 7 with entrained polymer film X-2597 were analyzed for contents of possible degradants of CIO2. Headspace samples underwent a colorimetric analysis for CIO2 gas. Residual juice and tomato samples (matrix) underwent an ion chromatography for the known CIO2 degradation products chlorate, chlorite, and
chloride. Initial studies involving spiking the product matrices with CIO2 gas showed no detectable chlorine dioxide in the residual juice and tomato samples, possibly due to the active redox environment as a result of the native ascorbic acid. Thus, the matrix was not analyzed for chlorine dioxide.
[0204] Headspace CIO2 concentration was measured up to 48 hours (results after 36 hrs not shown in Table 12 below). After about 16 hours, no headspace CIO2 was detected.
Table 12. Headspace CIO2 concentration (data from 36 hrs to 48 hrs omitted).
“<” indicates no detected chlorine dioxide above the instruments detection limit given.
[0205] Results of the tomato slices are shown in Table 13 below.
Table 13. Content analysis of tomato slices.
“<” indicates no detected chlorine dioxide above the instruments detection limits given.
[0206] Results of degradant contents of the tomato juice are shown in Table 14 below.
Table 14. Content analysis of tomato juice.
“<” indicates no detected chlorine dioxide above the instruments detection limits given.
[0207] Additionally, tomato slice extracts and juice sample were spiked with chlorate, chlorite, and chloride to determine the matrix effects. The chlorite recoveries were low, ranging from 0-69%, likely due to the redox power of the matrix. On the other hand, chloride recoveries were high, ranging from 137% to 151%, indicating conversion from chlorite to chloride. Chlorate recoveries were from 100% to 110%, indicating its stability in the matrix. The results suggest that the matrix provided by the tomatoes promotes conversion of chlorite to chloride, at least at the spike concentrations.
[0208] While the invention has been described in detail and with reference to specific examples thereof, it will be apparent to one skilled in the art that various changes and
modifications can be made therein without departing from the spirit and scope thereof.